Development of neoplasms in pediatric patients with rheumatic disease exposed to anti-tumor necrosis factor therapies: a single Centre retrospective study

BACKGROUND: Anti-TNF (Tumor necrosis factor) therapy is effective in treating pediatric patients with refractory rheumatic disease. There is however a concern that anti-TNF usage may increase the risk of malignancy. Reports on specific types of malignancy in this patient population have been emergin...

Descripción completa

Detalles Bibliográficos
Autores principales: Okihiro, Alexandra, Hasija, Rachana, Fung, Lillia, Cameron, Bonnie, Feldman, Brian M., Laxer, Ronald, Schneider, Rayfel, Silverman, Earl, Spiegel, Lynn, Yeung, Rae S. M., Tse, Shirley M. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853069/
https://www.ncbi.nlm.nih.gov/pubmed/29540190
http://dx.doi.org/10.1186/s12969-018-0233-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853069/
https://www.ncbi.nlm.nih.gov/pubmed/29540190
http://dx.doi.org/10.1186/s12969-018-0233-1

Ejemplares similares